Antibacterial consumption before, during, and after the COVID-19 pandemic in a tertiary care pediatric hospital in Mexico
PLOS One · 2025
DOI: 10.1371/journal.pone.0329220 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Ana Mayra Pérez-Morales und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiological Research, Hospital Infantil de México Federico Gómez, Mexico City, Mexico. Hauptthemen laut MEDLINE: COVID-19, Anti-Bacterial Agents, Hospitals, Pediatric. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.
Abstract (Originalsprache)
Background
During the coronavirus disease 2019 (COVID-19) pandemic, pediatric inpatients frequently received at least one antibiotic, and several antimicrobial stewardship programs (ASPs) strategies were disrupted. In Mexico, no published data are available on antibacterial consumption in children. The aim of this study was to evaluate antibacterial consumption levels and trends before, during, and after the COVID-19 pandemic in a tertiary care pediatric hospital in Mexico, and to forecast future antibacterial consumption.
Methods
This was a secondary analysis based on time series data of monthly antibacterial consumption from January 2016 to June 2024 in a tertiary care pediatric hospital. Antibacterial consumption was retrospectively measured for the pre-pandemic, pandemic, and post-pandemic periods. Consumption was expressed as days of therapy (DOT) per 1000 patient-days (pd).
Results
The mean antibacterial consumption at the Hospital Infantil de México Federico Gómez (HIMFG) from 2016 to 2024 was 789.3 (95% CI, 756.1–822.5) DOT/1000 pd. In the medical pediatric intensive care unit (M-PICU) and surgical pediatric intensive care unit (S-PICU), mean consumption was 1305.3 DOT/1000 pd (95% CI: 1119.1–1491.6) and 1634.5 DOT/1000 pd (95% CI: 1444.2–1824.9), respectively. Before the pandemic, the hospital-wide mean consumption was 848.8 DOT/1000 pd (95% CI: 811.3–886.2); during the pandemic, it was 709.6 DOT/1000 pd (95% CI: 650.3–769.0); and after the pandemic, 799.2 DOT/1000 pd (95% CI: 698.1–900.3). Overall, consumption rates oscillated around the mean, and no patterns were observed.
Conclusions
The COVID-19 pandemic did not affect trends of antibacterial consumption across the hospital or in the pediatric intensive care unit. Although the prior authorization component of the ASP maintained antibacterial consumption around the mean, the implementation of additional ASP strategies -such as education and persuasive interventions- alongside current restrictive measures may help further optimize antibacterial consumption in pediatric units.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Epidemiological Research, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
- Department of Pediatric Infectious Diseases, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
- Evaluation of Drug and Pharmacovigilance Research Unit, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
- Center for Health Economic and Social Studies, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
- Clinical Epidemiology Research Unit-Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico.
- Pharmaceutical Services, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
ORCID-Profile: Alfonso Reyes-López, Jessica Liliana Vargas-Neri
Förderung
- Pfizer
Zitieren
APA
Pérez-Morales, A. M., Jiménez-Juárez, R. N., Morales-Ríos, O. M., Reyes-López, A., Clark, P., Islas-Ortega, E. J., Ortega-Riosvelasco, F., Gómez-Gaytán, H., Castellanos-Cruz, M. D. C., Vargas-Neri, J. L., & Group of Collaboration ASP-HIM (2025). Antibacterial consumption before, during, and after the COVID-19 pandemic in a tertiary care pediatric hospital in Mexico. PLOS One. https://doi.org/10.1371/journal.pone.0329220
Vancouver
Pérez-Morales AM, Jiménez-Juárez RN, Morales-Ríos OM, Reyes-López A, Clark P, Islas-Ortega EJ, et al. Antibacterial consumption before, during, and after the COVID-19 pandemic in a tertiary care pediatric hospital in Mexico. PLOS One. 2025. doi:10.1371/journal.pone.0329220
BibTeX
@article{PrezMorales2025,
author = {Pérez-Morales, Ana Mayra and Jiménez-Juárez, Rodolfo Norberto and Morales-Ríos, Olga Magdala and Reyes-López, Alfonso and Clark, Patricia and Islas-Ortega, Erika Janet and Ortega-Riosvelasco, Fernando and Gómez-Gaytán, Heriberto and Castellanos-Cruz, María Del Carmen and Vargas-Neri, Jessica Liliana and Group of Collaboration ASP-HIM, Group of Collaboration ASP-HIM},
title = {Antibacterial consumption before, during, and after the COVID-19 pandemic in a tertiary care pediatric hospital in Mexico},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0329220}
}
EUVIMED